Publications by authors named "Rob Elston"

Claim this Profile
S
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.
Maria Buti, Jeong Heo, Yasuhito Tanaka, Pietro Andreone, Masanori Atsukawa, Rob Elston

J Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleos(t)ide Analog Treatment Discontinuation in Chronic Hepatitis B Virus Infection: A Systematic Literature Review.
Robert Gish, Kosh Agarwal, Anadi Mahajan, Supriya Desai, Saifuddin Kharawala, Rob Elston

Gastro Hep Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.
Edward J Gane, Stuart K Roberts, Catherine A M Stedman, Peter W Angus, Brett Ritchie, Rob Elston

Lancet· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of resistance during first-line treatment with boosted fosamprenavir is associated with baseline mutations.
Dirk Schürmann, Rob Elston, Fan Xu, Niels Kleinkauf, Thomas Wünsche

AIDS· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides.
Helena Sterlinko Grm, Malte Weber, Rob Elston, Pauline McIntosh, Heather Griffin

J Mol Biol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis